Epigenetic Regulation by Polycomb Group Complexes: Focus on Roles of CBX Proteins

Overview

Journal J Zhejiang Univ Sci B

Specialties Biology
General Medicine

Date 2014 May 6

PMID 24793759

Citations 52

Authors

Rong-gang Ma

Yang Zhang

Ting-Ting Sun

Bo Cheng

Affiliations

Soon will be listed here.

Abstract

Polycomb group (PcG) complexes are epigenetic regulatory complexes that conduct transcriptional repression of target genes via modifying the chromatin. The two best characterized forms of PcG complexes, polycomb repressive complexes 1 and 2 (PRC1 and PRC2), are required for maintaining the stemness of embryonic stem cells and many types of adult stem cells. The spectra of target genes for PRCs are dynamically changing with cell differentiation, which is essential for proper decisions on cell fate during developmental processes. Chromobox (CBX) family proteins are canonical components in PRC1, responsible for targeting PRC1 to the chromatin. Recent studies highlight the function specifications among CBX family members in undifferentiated and differentiated stem cells, which reveal the interplay between compositional diversity and functional specificity of PRC1. In this review, we summarize the current knowledge about targeting and functional mechanisms of PRCs, emphasizing the recent breakthroughs related to CBX proteins under a number of physiological and pathological conditions.

Citing Articles

Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer.

Wahab M, Del Gaudio N, Gargiulo B, Quagliariello V, Maurea N, Nebbioso A Cancers (Basel). 2024; 16(17).

PMID: 39272883 PMC: 11394081. DOI: 10.3390/cancers16173026.

CBX2 enhances the progression and TMZ chemoresistance of glioma via EZH2-mediated epigenetic silencing of PTEN expression.

Wang J, Yang B, Wang Y, Liu S, Ma C, Piao J Front Pharmacol. 2024; 15:1430891.

PMID: 39114365 PMC: 11303140. DOI: 10.3389/fphar.2024.1430891.

Identification of prognostic stemness-related genes in kidney renal papillary cell carcinoma.

Liu Y, Yao Y, Zhang Y, Xu C, Yang T, Qu M BMC Med Genomics. 2024; 17(1):121.

PMID: 38702698 PMC: 11067181. DOI: 10.1186/s12920-024-01870-2.

The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos.

Shao R, Suzuki T, Suyama M, Tsukada Y BMC Genomics. 2024; 25(1):143.

PMID: 38317092 PMC: 10840191. DOI: 10.1186/s12864-024-10029-3.

Decoding the interaction between miR-19a and CBX7 focusing on the implications for tumor suppression in cancer therapy.

Zabeti Touchaei A, Vahidi S, Samadani A Med Oncol. 2023; 41(1):21.

PMID: 38112798 DOI: 10.1007/s12032-023-02251-y.

References

Hinz S, Kempkensteffen C, Christoph F, Krause H, Schrader M, Schostak M . Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance. Tumour Biol. 2008; 29(5):323-9. DOI: 10.1159/000170879. View

Li B, Zhou J, Liu P, Hu J, Jin H, Shimono Y . Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a. Biochem J. 2007; 405(2):369-78. PMC: 1904525. DOI: 10.1042/BJ20061873. View

Shinjo K, Yamashita Y, Yamamoto E, Akatsuka S, Uno N, Kamiya A . Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation. Int J Cancer. 2013; 135(2):308-18. DOI: 10.1002/ijc.28692. View

Yap K, Li S, Munoz-Cabello A, Raguz S, Zeng L, Mujtaba S . Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38(5):662-74. PMC: 2886305. DOI: 10.1016/j.molcel.2010.03.021. View

Wang B, Tang J, Liao D, Wang G, Zhang M, Sang Y . Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma. Ann Surg Oncol. 2013; 20 Suppl 3:S684-92. DOI: 10.1245/s10434-013-3171-7. View

Crea F, Paolicchi E, Marquez V, Danesi R . Polycomb genes and cancer: time for clinical application?. Crit Rev Oncol Hematol. 2011; 83(2):184-93. DOI: 10.1016/j.critrevonc.2011.10.007. View

Ren X, Vincenz C, Kerppola T . Changes in the distributions and dynamics of polycomb repressive complexes during embryonic stem cell differentiation. Mol Cell Biol. 2008; 28(9):2884-95. PMC: 2293085. DOI: 10.1128/MCB.00949-07. View

Brown J, Kassis J . Architectural and functional diversity of polycomb group response elements in Drosophila. Genetics. 2013; 195(2):407-19. PMC: 3781969. DOI: 10.1534/genetics.113.153247. View

Dietrich N, Bracken A, Trinh E, Schjerling C, Koseki H, Rappsilber J . Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus. EMBO J. 2007; 26(6):1637-48. PMC: 1829390. DOI: 10.1038/sj.emboj.7601632. View

10.

Muller J, Verrijzer P . Biochemical mechanisms of gene regulation by polycomb group protein complexes. Curr Opin Genet Dev. 2009; 19(2):150-8. DOI: 10.1016/j.gde.2009.03.001. View

11.

Atchison L, Ghias A, Wilkinson F, Bonini N, Atchison M . Transcription factor YY1 functions as a PcG protein in vivo. EMBO J. 2003; 22(6):1347-58. PMC: 151054. DOI: 10.1093/emboj/cdg124. View

12.

Agrawal N, Banerjee R . Human polycomb 2 protein is a SUMO E3 ligase and alleviates substrate-induced inhibition of cystathionine beta-synthase sumoylation. PLoS One. 2008; 3(12):e4032. PMC: 2606060. DOI: 10.1371/journal.pone.0004032. View

13.

Muller J, Gaunt S, Lawrence P . Function of the Polycomb protein is conserved in mice and flies. Development. 1995; 121(9):2847-52. DOI: 10.1242/dev.121.9.2847. View

14.

Hannafon B, Sebastiani P, de las Morenas A, Lu J, Rosenberg C . Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res. 2011; 13(2):R24. PMC: 3219184. DOI: 10.1186/bcr2839. View

15.

Merrill J, Kagey M, Melhuish T, Powers S, Zerlanko B, Wotton D . Inhibition of CtBP1 activity by Akt-mediated phosphorylation. J Mol Biol. 2010; 398(5):657-71. PMC: 2866129. DOI: 10.1016/j.jmb.2010.03.048. View

16.

Richly H, Aloia L, Di Croce L . Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis. 2011; 2:e204. PMC: 3186902. DOI: 10.1038/cddis.2011.84. View

17.

Biason-Lauber A, Konrad D, Meyer M, deBeaufort C, Schoenle E . Ovaries and female phenotype in a girl with 46,XY karyotype and mutations in the CBX2 gene. Am J Hum Genet. 2009; 84(5):658-63. PMC: 2680992. DOI: 10.1016/j.ajhg.2009.03.016. View

18.

Schorderet P, Lonfat N, Darbellay F, Tschopp P, Gitto S, Soshnikova N . A genetic approach to the recruitment of PRC2 at the HoxD locus. PLoS Genet. 2013; 9(11):e1003951. PMC: 3820793. DOI: 10.1371/journal.pgen.1003951. View

19.

Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H . Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007; 131(6):1190-203. DOI: 10.1016/j.cell.2007.11.025. View

20.

Zhou X, Zhang H, Gu G, Ding Y, Jia J, Fu Q . Investigation of the relationship between chromobox homolog 8 and nucleus pulposus cells degeneration in rat intervertebral disc. In Vitro Cell Dev Biol Anim. 2013; 49(4):279-86. DOI: 10.1007/s11626-013-9596-2. View